NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Hesperidin RCT in MS

RecruitingNA

Sponsor: Swansea University

Conditions: Multiple Sclerosis

Interventions: Hesperidin, Placebo

Countries: United Kingdom

This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of Multiple Sclerosis, Aged 18 years or older.

Exclusion Criteria:

* Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.

Locations (1)

Swansea, Wales, United Kingdom